The Role of pH Monitoring in Refractory GERD

Persistent heartburn, regurgitation, chest discomfort, or cough can continue even when a patient takes a proton pump inhibitor (PPI) correctly. This situation is often described as refractory gastroesophageal reflux disease (GERD), but ongoing symptoms do not automatically prove that acid reflux remains the cause.

Ambulatory pH monitoring helps separate uncontrolled acid exposure from reflux hypersensitivity, functional heartburn, non-acid reflux, and unrelated gastrointestinal or cardiopulmonary conditions. Used alongside endoscopy and esophageal manometry, it can turn an uncertain diagnosis into a more targeted treatment plan.

The test is particularly valuable when symptoms are troublesome, the diagnosis is uncertain, or invasive therapy is being considered. Its timing and interpretation depend on whether GERD has already been objectively established.

Why Symptoms Persist During Treatment

A PPI reduces gastric acid production, yet it may not stop the physical movement of stomach contents into the esophagus. Patients can therefore experience weakly acidic or non-acid reflux, especially after meals or when lying down. Reflux events may also trigger symptoms through esophageal sensitivity rather than tissue injury.

Medication use can create another source of confusion. Incorrect timing, missed doses, rapid metabolism, or an inadequate regimen may limit effectiveness. Some symptoms attributed to GERD may instead arise from rumination, supragastric belching, eosinophilic esophagitis, achalasia, or functional disorders.

When Ambulatory Testing Is Indicated

Testing is generally considered before long-term escalation when endoscopy has not shown conclusive erosive disease or when symptoms fail to respond to optimized therapy. For patients without established GERD, monitoring is usually performed off PPI treatment to determine whether abnormal acid exposure exists under baseline conditions.

When GERD has already been confirmed by severe erosive esophagitis, Barrett’s esophagus, or previous abnormal reflux testing, impedance-pH monitoring while the patient remains on PPI therapy may be more informative. It can show whether persistent symptoms correlate with residual acid, weakly acidic reflux, or a high number of reflux events.

The broader diagnostic landscape is also evolving, with technologies such as AI-assisted endoscopic screening supporting more consistent recognition of mucosal abnormalities. Endoscopy and pH monitoring answer different questions, so one cannot replace the other.

Choosing the Monitoring Strategy

The appropriate device depends on the clinical question, local expertise, and patient tolerance. Catheter-based studies provide detailed data and can combine pH measurement with impedance, while wireless systems offer longer monitoring with less visible equipment.

Before catheter placement, high-resolution manometry may be needed if dysphagia, atypical findings, or a motility disorder is suspected. It also helps locate the lower esophageal sphincter accurately for sensor positioning.

Reading Acid Exposure And Symptom Association

The central measurement is acid exposure time, which reflects the percentage of the recording during which esophageal pH remains below 4. Clinicians also review the number and duration of reflux episodes, the pattern during upright and supine periods, and whether symptoms occur soon after recorded events.

Symptom index and symptom association probability estimate the relationship between reported symptoms and reflux episodes. A positive association supports reflux-related symptoms, although a negative result does not always exclude them. The quality of the diary, the number of reported events, and day-to-day variability all affect reliability.

An abnormal acid burden supports GERD and may justify continued acid suppression or further evaluation. Normal acid exposure with positive symptom association suggests reflux hypersensitivity, while normal exposure and absent association point toward functional heartburn or another diagnosis.

Turning Findings Into Treatment Decisions

If monitoring shows abnormal reflux despite treatment, clinicians can review PPI timing, adherence, dose, meal patterns, body weight, alcohol intake, and medications that may worsen reflux. Persistent regurgitation may require consideration of alginate therapy, selected surgical options, or transoral procedures after careful anatomical and motility assessment.

A normal study can prevent unnecessary lifelong escalation of acid suppression. Depending on the findings, management may shift toward neuromodulators, behavioral therapy, dietary support, treatment for rumination or belching, or evaluation for non-esophageal causes.

Results should be interpreted with endoscopy, biopsy findings, manometry, and the patient’s dominant symptom. A test result separated from the clinical picture can lead to overtreatment or false reassurance.

Practical Recommendations For Better Testing

Successful monitoring depends on preparation and accurate reporting. Patients should receive clear instructions about medication withdrawal or continuation, meals, sleep, exercise, and symptom logging. Clinicians should document the exact PPI regimen and the reason for testing.

Useful steps include:

• Confirm whether GERD is proven before deciding between off-PPI and on-PPI monitoring.
• Review alarm symptoms, including progressive dysphagia, bleeding, anemia, weight loss, or persistent vomiting.
• Use impedance-pH monitoring when symptoms continue during PPI therapy and non-acid reflux is a concern.
• Record symptoms promptly and specifically rather than entering a general end-of-day summary.
• Interpret acid exposure, symptom association, endoscopy, and manometry as a combined clinical picture.

Patients with alarm features need timely diagnostic evaluation rather than relying on ambulatory monitoring alone. Likewise, those being assessed for antireflux surgery require objective evidence and appropriate esophageal motility testing.

From Measurement To Personalized Care

pH monitoring is most useful when it answers a clearly defined question: Is reflux present, is treatment controlling it, and do recorded reflux events explain the patient’s symptoms? Choosing the correct test conditions is as important as the numerical result.

A structured evaluation can reduce diagnostic uncertainty and direct treatment toward the actual mechanism. Healthcare professionals can use ambulatory reflux testing within a broader evidence-based assessment, while patients should discuss medication instructions and results with a qualified clinician before changing therapy.